UBS Group’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-793,902
| Closed | -$3.4M | – | 8762 |
|
|
2019
Q3 | $3.4M | Buy |
793,902
+484,346
| +156% | +$1.76M | ﹤0.01% | 2758 |
|
|
2019
Q2 | $922K | Buy |
309,556
+271,466
| +713% | +$680K | ﹤0.01% | 3814 |
|
|
2019
Q1 | $66K | Buy |
38,090
+24,090
| +172% | +$33.3K | ﹤0.01% | 5359 |
|
|
2018
Q4 | $12K | Sell |
14,000
-6,554
| -32% | -$7.82K | ﹤0.01% | 7171 |
|
|
2018
Q3 | $29K | Sell |
20,554
-79,135
| -79% | -$86.6K | ﹤0.01% | 6577 |
|
|
2018
Q2 | $82K | Buy |
99,689
+40,087
| +67% | +$38.7K | ﹤0.01% | 5596 |
|
|
2018
Q1 | $82K | Buy |
59,602
+6,515
| +12% | +$7.56K | ﹤0.01% | 5358 |
|
|
2017
Q4 | $53K | Sell |
53,087
-43,876
| -45% | -$49.6K | ﹤0.01% | 5805 |
|
|
2017
Q3 | $147K | Sell |
96,963
-35,269
| -27% | -$59.1K | ﹤0.01% | 5062 |
|
|
2017
Q2 | $246K | Buy |
132,232
+91,083
| +221% | +$121K | ﹤0.01% | 4616 |
|
|
2017
Q1 | $54K | Buy |
41,149
+32,552
| +379% | +$26.5K | ﹤0.01% | 5473 |
|
|
2016
Q4 | $6K | Buy |
+8,597
| New | +$7.24K | ﹤0.01% | 7185 |
|
|
2016
Q3 | – | Sell |
-703
| Closed | -$1K | – | 8107 |
|
|
2016
Q2 | $1K | Buy |
+703
| New | +$815 | ﹤0.01% | 7603 |
|
|
2015
Q4 | – | Sell |
-4,099
| Closed | -$13K | – | 8700 |
|
|
2015
Q3 | $13K | Buy |
4,099
+2,269
| +124% | +$8.19K | ﹤0.01% | 7098 |
|
|
2015
Q2 | $6K | Buy |
+1,830
| New | +$7.81K | ﹤0.01% | 7814 |
|
UBS Group's CVRS Position: Q4 2019 in Review
UBS Group sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 793,902 shares — an estimated $3.4M sold.
UBS Group first reported a position in CVRS in Q2 2015 and held it in 15 quarters. The position peaked at $3.4M in Q3 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.
- UBS Group reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
- UBS Group sold 793,902 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $3.4M.
- UBS Group first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2015 and held it in 15 quarters.
- UBS Group's CORINDUS VASCULAR ROBOTICS, INC position peaked at $3.4M in Q3 2019.
- 0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.